In the European study to establish bioMARKers of human AGEing (MARK-AGE), the relationship between plasma GDF15 levels, cognitive frailty, and depression was explored in 2736 participants, including individuals who were 55+ years and younger adults [53]. Here, GDF15 is linked to depressive disorder.